Product Application
hematological tumors
A Comprehensive Collection of Hot Target Proteins and Companion Antibodies for ADC Drugs
Currently, a total of 15 ADC drugs have been approved globally, with 7 of them available in the domestic market. These drugs are indicated for both solid tumors and hematologic malignancies. The 15 products target 11 distinct molecular targets.
View details
- ADC drugs
- solid tumors
- hematological tumors
- 1












